Current Neuro-Oncology
Volume
24 Number 12
30 June 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 12, 30 June
*
Del
Baldo G, Cacchione A, Dell'Anna VA, Merli P, Colafati GS, Marrazzo
A, Rossi S, Giovannoni I, Barresi S, Deodati A, Valente P,
Ferretti E, Capece M, Mastronuzzi A, Carai A.
Rethinking
the Management of Optic Pathway Gliomas: A Single Center
Experience.
Front
Surg. 2022 Jun 16;9:890875∟.
doi: 10.3389/fsurg.2022.890875∟.
PMID: 35784925∟.
Observational study. ˍ
Kang
X, Chen F, Yang SB, Wang YL, Qian ZH, Li Y, Lin H, Li P, Peng YC,
Wang XM, Li WB.
Intrathecal
methotrexate in combination with systemic chemotherapy in
glioblastoma patients with leptomeningeal dissemination: A
retrospective analysis.
World
J Clin Cases. 2022 Jun 16;10(17):5595-560∟.
doi: 10.12998/wjcc.v10.i17.5595∟.
PMID: 35979103∟.
Observational study. ˍ
Krigers
A, Pinggera D, Demetz M, Kornberger LM, Kerschbaumer J, Thomé
C, Freyschlag CF.
The
Routine Application of Tumor-Treating Fields in the Treatment of
Glioblastoma WHO° IV.
Front
Neurol. 2022 Jun 16;13:900377∟.
doi: 10.3389/fneur.2022.900377∟.
PMID: 35785334∟.
Observational study. ˍ
Schiavello
E, Biassoni V, Gattuso G, Podda M, Chiaravalli S, Barretta F,
Antonelli M, De Cecco L, Pecori E, Gandola L, Massimino M.
A
homogeneous treatment for non-DIPG diffuse midline glioma.
Tumori.
2022 Jun 16, 2022:3008916221099067∟.
doi: 10.1177/03008916221099067∟.
PMID: 35708347∟.
Observational study. ˍ
Li
Y, Jiang H, Wang X, Liu X, Huang Y, Wang Z, Ma Q, Dong L, Qi Y,
Zhang H, Lu G.
Crosstalk
Between the Gut and Brain: Importance of the Fecal Microbiota in
Patient With Brain Tumors.
Front
Cell Infect Microbiol. 2022 Jun 17;12:881071∟.
doi: 10.3389/fcimb.2022.881071∟.
PMID: 35782130∟.
Observational study.
ˍ
Schuelke
MR, Gundelach JH, Coffey M, West E, Scott K, Johnson DR, Samson A,
Melcher A, Vile RG, Bram RJ.
Phase
I trial of sargramostim/pelareorep therapy in pediatric patients
with recurrent or refractory high-grade brain tumors.
Neurooncol
Adv. 2022 Jun 17;4(1):vdac085∟.
doi: 10.1093/noajnl/vdac085∟.
PMID: 35821679∟.
Interventional
study.
ˍ
Trippett
T, Toledano H, Campbell Hewson Q, Verschuur A, Langevin AM, Aerts
I, Howell L, Gallego S, Rossig C, Smith A, Patel D, Pereira LR,
Cheeti S, Musib L, Hutchinson KE, Devlin C, Bernardi R, Geoerger
B.
Cobimetinib
in Pediatric and Young Adult Patients with Relapsed or Refractory
Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II
Study.
Target
Oncol. 2022 Jun 17;17(3):283-293∟.
doi: 10.1007/s11523-022-00888-9∟.
PMID: 35715627∟.
Interventional
study.
ˍ
Parakh
S, Davies A, Westcott K, Roos D, Abou-Hamden A, Ahern E, Lau PKH,
Cheruvu S, Pranavan G, Pullar A, Lynam J, Gzell C, Whittle JR,
Cain S, Inglis PL, Harrup R, Anazodo A, Hovey E, Cher L, Gan
HK.
Adult
medulloblastoma in an Australian population.
J
Clin Neurosci. 2022 Jun 18;102:65-70∟.
doi: 10.1016/j.jocn.2022.06.008∟.
PMID: 35728397∟.
Observational study˰ ˍ
Werner
JM, Wolf L, Tscherpel C, Bauer EK, Wollring M, Ceccon G, Deckert
M, Brunn A, Pappesch R, Goldbrunner R, Fink GR, Galldiks
N.
Efficacy
and tolerability of regorafenib in pretreated patients with
progressive CNS grade 3 or 4 gliomas.
J
Neurooncol. 2022 Jun 18∟.
doi: 10.1007/s11060-022-04066-9∟.
PMID: 35716310∟.
Observational study. ˍ
Lin
Q, Bao JH, Xue F, Qin JJ, Chen Z, Chen ZR, Li C, Yan YX, Fu J,
Shen ZL, Chen XZ.
The
Risk of Heart Disease-Related Death Among Anaplastic Astrocytoma
Patients After Chemotherapy: A SEER Population-Based
Analysis.
Front
Oncol. 2022 Jun 20;12:870843∟.
doi: 10.3389/fonc.2022.870843∟.
PMID: 35795052∟.
Observational study. ˍ
Natsume
A, Arakawa Y, Narita Y, Sugiyama K, Hata N, Muragaki Y, Shinojima
N, Kumabe T, Saito R, Motomura K, Mineharu Y, Miyakita Y, Yamasaki
F, Matsushita Y, Ichimura K, Ito K, Tachibana M, Kakurai Y,
Okamoto N, Asahi T, Nishijima S, Yamaguchi T, Tsubouchi H,
Nakamura H, Nishikawa R.
The
first-in-human phase I study of a brain penetrant mutant IDH1
inhibitor DS-1001 in patients with recurrent or progressive
IDH1-mutant gliomas.
Neuro
Oncol. 2022 Jun 20, 2022:noac155∟.
doi: 10.1093/neuonc/noac155∟.
PMID: 35722822∟.
Interventional
study.
ˍ
Treiber
H, von der Brelie C, Malinova V, Mielke D, Rohde V, Chapuy
CI.
Regorafenib
for recurrent high-grade glioma: a unicentric retrospective
analysis of feasibility, efficacy, and toxicity.
Neurosurg
Rev. 2022 Jun 20∟.
doi: 10.1007/s10143-022-01826-z∟.
PMID: 35725846∟.
Observational study. ˍ
Chavaz
L, Janssens GO, Bolle S, Mandeville H, Ramos-Albiac M, Van Beek K,
Benghiat H, Hoeben B, Morales La Madrid A, Seidel C, Kortmann RD,
Hargrave D, Gandola L, Pecori E, van Vuurden DG, Biassoni V,
Massimino M, Kramm CM, von Bueren AO.
Neurological
Symptom Improvement After Re-Irradiation in Patients With Diffuse
Intrinsic Pontine Glioma: A Retrospective Analysis of the
SIOP-E-HGG/DIPG Project.
Front
Oncol. 2022 Jun 22;12:926196∟.
doi: 10.3389/fonc.2022.926196∟.
PMID: 35814457∟.
Observational study. ˍ
Parney
IF, Anderson SK, Gustafson MP, Steinmetz S, Peterson TE, Kroneman
TN, Raghunathan A, O'Neill BP, Buckner JC, Solseth M, Dietz
AB.
Phase
I trial of adjuvant mature autologous dendritic cell/allogeneic
tumor lysate vaccines in combination with temozolomide in newly
diagnosed glioblastoma.
Neurooncol
Adv. 2022 Jun 24;4(1):vdac089∟.
doi: 10.1093/noajnl/vdac089∟.
PMID: 35967100∟.
Interventional study. ˍ
Stoyanov
GS, Lyutfi E, Georgiev R, Dzhenkov DL, Kaprelyan A.
The
Rapid Development of Glioblastoma: A Report of Two Cases.
Cureus.
2022 Jun 25;14(6):e26319∟.
doi: 10.7759/cureus.26319∟.
PMID: 35911333∟.
Case report. ˍ
Uluc
K, Ambady P, McIntyre MK, Tabb JP, Kersch CN, Nerison CS,
Huddleston A, Liu JJ, Dogan A, Priest RA, Fu R, Prola Netto J,
Siler DA, Muldoon LL, Gahramanov S, Neuwelt EA.
Safety
of intra-arterial chemotherapy with or without osmotic blood-brain
barrier disruption for the treatment of patients with brain
tumors.
Neurooncol
Adv. 2022 Jun 25;4(1):vdac104∟.
doi: 10.1093/noajnl/vdac104∟.
PMID: 35892048∟.
Observational study. ˍ
Li
S, Guo F, Wang X, Zeng J, Hong J.
Timing
of radiotherapy in glioblastoma based on IMRT and STUPP
chemo-radiation: may be no need to rush.
Clin
Transl Oncol. 2022 Jun 26∟.
doi: 10.1007/s12094-022-02867-y∟.
PMID: 35753023∟.
Observational study˰ ˍ
Bota
DA, Taylor TH, Lomeli N, Kong XT, Fu BD, Schönthal AH, Singer
S, Blumenthal DT, Senecal FM, Linardou H, Rokas E, Antoniou DG,
Schijns VEJC, Chen TC, Elliot J, Stathopoulos A.
A
Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When
Given in Combination With Granulocyte-Macrophage
Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab
or Granulocyte-Macrophage Colony-Stimulating
Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who
Failed Prior Treatment With Surgical Resection, Radiation, and
Temozolomide.
Front
Oncol. 2022 Jun 28;12:934638∟.
doi: 10.3389/fonc.2022.934638∟.
PMID: 35837107∟.
Interventional study. ˍ
Brown
NF, Ottaviani D, Tazare J, Gregson J, Kitchen N, Brandner S,
Fersht N, Mulholland P.
Survival
Outcomes and Prognostic Factors in Glioblastoma.
Cancers
(Basel). 2022 Jun 28;14(13):3161∟.
doi: 10.3390/cancers14133161∟.
PMID: 35804940∟.
Observational study. ˍ
Hirano
Y, Shinya Y, Aono T, Hasegawa H, Kawashima M, Shin M, Takami H,
Takayanagi S, Umekawa M, Ikemura M, Ushiku T, Taoka K, Tanaka S,
Saito N.
The
Role of Stereotactic Frame-Based Biopsy for Brainstem Tumors in
the Era of Molecular-Based Diagnosis and Treatment Decisions.
Curr
Oncol. 2022 Jun 28;29(7):4558-4565∟.
doi: 10.3390/curroncol29070360∟.
PMID: 35877220∟.
Observational study. ˍ
Stewart
J, Sahgal A, Chan AKM, Soliman H, Tseng CL, Detsky J, Myrehaug S,
Atenafu EG, Helmi A, Perry J, Keith J, Jane Lim-Fat M, Munoz DG,
Zadeh G, Shultz DB, Das S, Coolens C, Alcaide-Leon P, Maralani
PJ.
Pattern
of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant
Astrocytoma Following Chemoradiation: A Retrospective
Matched-Cohort Analysis.
Technol
Cancer Res Treat. 2022 Jun 28;21:15330338221109650∟.
doi: 10.1177/15330338221109650∟.
PMID: 35762826∟.
Observational study. ˍ
Yağcı-Küpeli
B, Pehlivan D.
Bevacizumab-containing
regimens for children with relapsed or refractory tumors.
Indian
J Cancer. 2022 Jun 29∟.
doi: 10.4103/ijc.IJC_907_20(?). PMID: 36861699∟.
Observational study. ˍ
de
Laurentis C, Cristaldi PMF, Rebora P, Valsecchi MG, Biassoni V,
Schiavello E, Carrabba GG, Trezza A, DiMeco F, Ferroli P, Cinalli
G, Locatelli M, Cenzato M, Talamonti G, Fontanella MM, Spena G,
Stefini R, Bernucci C, Bellocchi S, Locatelli D, Massimino M,
Giussani C.
Posterior
fossa syndrome in a population of children and young adults with
medulloblastoma: a retrospective, multicenter Italian study on
incidence and pathophysiology in a histologically homogeneous and
consecutive series of 136 patients.
J
Neurooncol. 2022 Jun 29∟.
doi: 10.1007/s11060-022-04072-x∟.
PMID: 35767101∟.
Observational study˰ ˍ
Al-Taei
O, Al-Mirza A, Al Kalbani H, Ali M, Al-Saadi T.
Anti-Epileptic
Drugs in Geriatric Neurosurgery: A Review of 669 Neurosurgical
Cases.
J
Epilepsy Res. 2022 Jun 30;12(1):27-32∟.
doi: 10.14581/jer.22005∟.
PMID: 35910329∟.
Observational study. ˍ
Endo
T, Inoue T, Mizuno M, Kurokawa R, Ito K, Ueda S, Takami T, Hida K,
Hoshimaru M.
Current
Trends in the Surgical Management of Intramedullary Tumors: A
Multicenter Study of 1,033 Patients by the Neurospinal Society of
Japan.
Neurospine.
2022 Jun 30;19(2):441-452∟.
doi: 10.14245/ns.2244156.078∟.
PMID: 35793935∟.
Observational study. ˍ
Gállego
Pérez-Larraya J, Garcia-Moure M, Labiano S, Patiño-García
A, Dobbs J, Gonzalez-Huarriz M, Zalacain M, Marrodan L,
Martinez-Velez N, Puigdelloses M, Laspidea V, Astigarraga I,
Lopez-Ibor B, Cruz O, Oscoz Lizarbe M, Hervas-Stubbs S,
Alkorta-Aranburu G, Tamayo I, Tavira B, Hernandez-Alcoceba R,
Jones C, Dharmadhikari G, Ruiz-Moreno C, Stunnenberg H, Hulleman
E, van der Lugt J, Idoate MÁ, Diez-Valle R, Esparragosa
Vázquez I, Villalba M, de Andrea C, Núñez-Córdoba
JM, Ewald B, Robbins J, Fueyo J, Gomez-Manzano C, Lang FF, Tejada
S, Alonso MM.
Oncolytic
DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
N
Engl J Med. 2022 Jun 30;386(26):2471-2481∟.
doi: 10.1056/NEJMoa2202028∟.
PMID: 35767439∟.
Observational study˰
ˍ